Articles related to MULTIPLE SCLEROSIS (MS)

High-dose vitamin D demonstrated a 34% reduced risk of disease activity in both CIS and early RRMS patients, with MRI markers showing particular improvement, though no significant impact on clinical symptoms or disability progression was observed.

“The bottom line to me is that it is just further evidence that you really can modify immune phenotypes [characteristics] with dietary interventions.”

Early use of high-efficacy disease-modifying therapies in pediatric-onset MS patients with minimal disability reduces the risk of progression by 59% compared to no treatment.

A recent study involving 230 untreated relapsing-remitting MS patients found that vitamin D levels below 20 ng/mL were associated with a more than twofold increase in the risk of disease activity. This finding emphasizes the potential importance of vitamin D monitoring and management in MS patient care.

Recent systematic reviews suggest a subtle increase in NMOSD and MS risks post-COVID-19 vaccination, primarily affecting genetically susceptible individuals.

This study of more than 1,100 MS patients reveals a significant perception of higher empathy in AI-generated responses compared to those from neurologists, underlining the potential to tailor AI communication tools to improve patient interactions.